Eisai

Eisai's Chinese subsidiary completed a new oral solid dose production facility and administration building at its Suzhou plant in the Suzhou Industrial Park. The facility has capacity for approximately 3 billion tablets formulation and 5 billion tablets packaging per year, doubling the capacity of the current plant.